U.S. Individual Tests Positive for Ebola Linked to Outbreak in Africa
A person in the United States has tested positive for Ebola, connected to a recent outbreak in the Democratic Republic of Congo and Uganda, according to the Centers for Disease Control and Prevention (CDC) on Monday.
The individual, who was exposed while working in Congo, showed symptoms over the weekend and received a positive test result late Sunday, said Dr. Satish Pillai, who manages the CDC’s Ebola response.
To ensure proper care, the CDC, in coordination with the Department of State, is arranging for the affected American to be treated in Germany. Six other individuals, identified as high-risk contacts, will also be moved to Germany for monitoring.
In a statement, the Christian missionary organization Serge announced that one of their medical missionaries tested positive for the Bundibugyo strain of the Ebola virus after treating patients at Nyankunde Hospital in Congo. The missionary’s family, including a doctor spouse, their four young children, and a colleague, are being closely monitored and relocated for specialized medical care.
The CDC has also announced restrictions for non-U.S. citizens who recently traveled to Uganda, Congo, or South Sudan, marking a precautionary measure to limit exposure.
Dr. Pillai reassured the public that the overall risk to the U.S. remains low. He urged travelers to the area to avoid contact with sick individuals, report any symptoms promptly, and follow travel advice.
The World Health Organization declared the outbreak a public health emergency over the weekend, reporting over 330 suspected cases and at least 88 suspected deaths in Congo. Uganda has recorded two confirmed cases, one of which resulted in death, linked to travel from Congo.
The Bundibugyo virus, responsible for the current outbreak, is known to cause a rare form of Ebola, for which there are currently no established vaccines or treatments. Previous outbreaks occurred in Uganda in 2007 and Congo in 2012, with fatality rates ranging from 30% to 50%, as per WHO data.
In an effort to combat the disease, the CDC and the Administration for Strategic Preparedness and Response are exploring monoclonal therapies that leverage antibodies to target the virus, showing potential in animal studies.
Ebola typically begins with fever, fatigue, muscle pain, headache, and sore throat, advancing to gastrointestinal symptoms and, in some cases, bleeding. The virus spreads through direct contact with bodily fluids or contaminated surfaces.
